Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone603-658-0411
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$42.38 million
Profitability
Miscellaneous
Employees276
Next Earnings Date11/5/2019 (Confirmed)
OptionableNot Optionable
Vapotherm (NYSE:VAPO) Frequently Asked Questions
What is Vapotherm's stock symbol?
Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."
How were Vapotherm's earnings last quarter?
Vapotherm Inc (NYSE:VAPO) issued its earnings results on Monday, July, 29th. The company reported ($0.76) EPS for the quarter, beating the Zacks' consensus estimate of ($0.81) by $0.05. The business earned $11.99 million during the quarter, compared to analyst estimates of $11.90 million. View Vapotherm's Earnings History.
When is Vapotherm's next earnings date?
How can I listen to Vapotherm's earnings call?
Vapotherm will be holding an earnings conference call on Tuesday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Vapotherm issued on next quarter's earnings?
Vapotherm issued an update on its FY 2019 earnings guidance on Monday, July, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $11-11.4 million, compared to the consensus revenue estimate of $11.92 million.
What price target have analysts set for VAPO?
4 brokerages have issued 1-year price targets for Vapotherm's shares. Their forecasts range from $26.00 to $27.00. On average, they anticipate Vapotherm's share price to reach $26.50 in the next twelve months. This suggests a possible upside of 157.3% from the stock's current price. View Analyst Price Targets for Vapotherm.
What is the consensus analysts' recommendation for Vapotherm?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Vapotherm.
Has Vapotherm been receiving favorable news coverage?
Media stories about VAPO stock have been trending negative recently, according to InfoTrie. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Vapotherm earned a news sentiment score of -2.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Vapotherm.
Are investors shorting Vapotherm?
Vapotherm saw a increase in short interest in September. As of September 30th, there was short interest totalling 530,500 shares, an increase of 124.6% from the August 30th total of 236,200 shares. Based on an average daily volume of 203,000 shares, the days-to-cover ratio is presently 2.6 days. Currently, 4.6% of the shares of the company are short sold. View Vapotherm's Current Options Chain.
Who are some of Vapotherm's key competitors?
Some companies that are related to Vapotherm include LeMaitre Vascular (LMAT), Cerus (CERS), SurModics (SRDX), Axonics Modulation Technologies (AXNX), Antares Pharma (ATRS), AngioDynamics (ANGO), Intersect ENT (XENT), Orthopediatrics (KIDS), OraSure Technologies (OSUR), MiMedx Group (MDXG), SI-Bone (SIBN), Utah Medical Products (UTMD), Alphatec (ATEC), GenMark Diagnostics (GNMK) and Pulse Biosciences (PLSE).
What other stocks do shareholders of Vapotherm own?
Who are Vapotherm's key executives?
Vapotherm's management team includes the folowing people:
- Mr. Joseph F. Army, CEO, Pres & Director (Age 55)
- Mr. William Niland, Founder
- Mr. John Landry, VP, CFO, Sec. & Treasurer (Age 47)
- Mr. John Coolidge, VP of Operations (Age 58)
- Mr. Anthony Ten Haagen, VP of Legal & Compliance
When did Vapotherm IPO?
(VAPO) raised $60 million in an initial public offering (IPO) on Wednesday, November 14th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.
How do I buy shares of Vapotherm?
Shares of VAPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Vapotherm's stock price today?
One share of VAPO stock can currently be purchased for approximately $10.30.
How big of a company is Vapotherm?
Vapotherm has a market capitalization of $180.24 million and generates $42.38 million in revenue each year. The company earns $-42,470,000.00 in net income (profit) each year or ($13.83) on an earnings per share basis. Vapotherm employs 276 workers across the globe.View Additional Information About Vapotherm.
What is Vapotherm's official website?
How can I contact Vapotherm?
Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company can be reached via phone at 603-658-0411 or via email at [email protected]
MarketBeat Community Rating for Vapotherm (NYSE VAPO)
MarketBeat's community ratings are surveys of what our community members think about Vapotherm and other stocks. Vote "Outperform" if you believe VAPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
